Napoli Nicola, Strotmeyer Elsa S, Ensrud Kristine E, Sellmeyer Deborah E, Bauer Douglas C, Hoffman Andrew R, Dam Thuy-Tien L, Barrett-Connor Elizabeth, Palermo Lisa, Orwoll Eric S, Cummings Steven R, Black Dennis M, Schwartz Ann V
Division of Endocrinology and Diabetes, Università Campus Bio-Medico di Roma, Via Alvaro del Portillo, Rome, Italy,
Diabetologia. 2014 Oct;57(10):2057-65. doi: 10.1007/s00125-014-3289-6. Epub 2014 Jun 9.
AIMS/HYPOTHESIS: Diabetes mellitus is associated with increased fracture risk in women but few studies are available in men. To evaluate the relationship between diabetes and prospective non-vertebral fractures in elderly men, we used data from the Osteoporotic Fractures in Men (MrOS) study.
The MrOS enrolled 5,994 men (aged ≥65 years). Diabetes (ascertained by self-report, the use of medication for diabetes or an elevated fasting glucose level) was reported in 881 individuals, 80 of whom were using insulin. Hip and spine bone mineral density (BMD) was measured using dual x-ray absorptiometry (DXA). After recruitment, the men were followed for incident non-vertebral fractures using a triannual (3 yearly) questionnaire for an average of 9.1 (SD 2.7) years. The Cox proportional hazards model was used to assess the incident risk of fractures.
In models adjusted for age, race, clinic site and total hip BMD, the risk of non-vertebral fracture was higher in men with diabetes compared with normoglycaemic men (HR 1.30, 95% CI 1.09, 1.54) and was elevated in men using insulin (HR 2.46, 95% CI 1.69, 3.59). Men with impaired fasting glucose did not have a higher risk of fracture compared with normoglycaemic men (HR 1.04, 95% CI 0.89, 1.21). After multivariable adjustment, the risk of non-vertebral fracture remained higher only among men with diabetes who were using insulin (HR 1.74, 95% CI 1.13, 2.69).
CONCLUSIONS/INTERPRETATION: Men with diabetes who are using insulin have an increased risk of non-vertebral fracture for a given age and BMD.
目的/假设:糖尿病与女性骨折风险增加有关,但针对男性的相关研究较少。为评估老年男性糖尿病与前瞻性非椎体骨折之间的关系,我们使用了男性骨质疏松性骨折(MrOS)研究的数据。
MrOS研究纳入了5994名男性(年龄≥65岁)。881人报告患有糖尿病(通过自我报告、糖尿病用药情况或空腹血糖水平升高确定),其中80人使用胰岛素。采用双能X线吸收法(DXA)测量髋部和脊柱骨密度(BMD)。招募后,使用每三年一次的问卷对男性进行随访,以了解非椎体骨折的发生情况,平均随访9.1(标准差2.7)年。采用Cox比例风险模型评估骨折的发生风险。
在对年龄、种族、诊所地点和全髋部骨密度进行调整的模型中,与血糖正常的男性相比,糖尿病男性发生非椎体骨折的风险更高(风险比1.30,95%置信区间1.09,1.54),使用胰岛素的男性风险更高(风险比2.46,95%置信区间1.69,3.59)。与血糖正常的男性相比,空腹血糖受损的男性骨折风险并未升高(风险比1.04,95%置信区间0.89,1.21)。经过多变量调整后,仅在使用胰岛素的糖尿病男性中,非椎体骨折的风险仍然较高(风险比1.74,95%置信区间1.13,2.69)。
结论/解读:在特定年龄和骨密度条件下,使用胰岛素的糖尿病男性发生非椎体骨折的风险增加。